These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8457478)

  • 1. Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo.
    Higgins JA; Giangrande PL; Kernoff PB; Goodall AH
    Br J Haematol; 1993 Feb; 83(2):296-305. PubMed ID: 8457478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
    Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
    Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermediate- and high-purity factor VIII concentrates on immune function in HIV-seropositive haemophiliacs as assessed by quantitative CD 4 counts.
    Deitcher SR; Tuller J; Dugdale M
    Haemophilia; 1997 Oct; 3(4):265-9. PubMed ID: 27214862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
    Lorenzo JI; Molina R; Aznar JA
    Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the aetiological role of blood-borne virus infections in causing reduced lectin-induced T-cell proliferation in haemophilic boys.
    Evans JA; Pasi KJ; Hill FG
    Br J Haematol; 1995 Sep; 91(1):197-202. PubMed ID: 7577632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR analysis of HIV-1 sequences and differential immunological features in seronegative and seropositive haemophiliacs.
    Chelucci C; Hassan HJ; Gringeri A; Macioce G; Mariani G; Santagostino E; Testa U; Vulcano F; Mannucci PM; Peschle C
    Br J Haematol; 1992 Aug; 81(4):558-67. PubMed ID: 1390244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
    Cuthbert RJ; Ludlam CA; Steel CM; Beatson D; Peutherer JF
    Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
    Gjerset GF; Pike MC; Mosley JW; Hassett J; Fletcher MA; Donegan E; Parker JW; Counts RB; Zhou Y; Kasper CK
    Blood; 1994 Sep; 84(5):1666-71. PubMed ID: 7915149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
    Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
    Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.
    Hilgartner MW; Buckley JD; Operskalski EA; Pike MC; Mosley JW
    Lancet; 1993 May; 341(8857):1373-4. PubMed ID: 8098792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a very high-purity factor VIII concentrate on the immune system of HIV-infected haemophiliacs: a randomized, two-year comparison with a high-purity concentrate.
    de Biasi R; Rocino A; Quirino AA; Miraglia E; Ziello L
    Haemophilia; 1996 Apr; 2(2):82-7. PubMed ID: 27214013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
    Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
    Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. II. Improvements of CD4/CD8 ratio after treatments with heat-inactivated factor concentrates.
    Shen MC; Hu FC; Lin JS; Tsai W; Fon MF; Wang EC
    Haemophilia; 1998 Jan; 4(1):33-40. PubMed ID: 9873863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
    Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
    Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y).
    Evans JA; Pasi KJ; Williams MD; Hill FG
    Br J Haematol; 1991 Nov; 79(3):457-61. PubMed ID: 1751373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive study of immunological abnormalities in Korean hemophiliacs.
    Kim KY; Yang CH; Kang SH; Kim DS
    Yonsei Med J; 1989; 30(2):180-5. PubMed ID: 2508331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
    Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H
    Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infection and immunity disorders in patients with hemophilia].
    Gotić M; Rolović Z; Brkić S; Vucković S; Bujko M; Lilić D; Dujić A
    Srp Arh Celok Lek; 1989; 117(11-12):737-50. PubMed ID: 2490991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
    Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
    Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.